Načítá se...
1404. A Pharmacokinetic Study on CMS and Colistin and Its Impact on Clinical Cure and Acute Kidney Injury in Critically Ill Patients with Normal Renal Function from South India
BACKGROUND: Colistin has re-emerged as last line antimicrobial to combat MDR GNB. There is need for robust pharmacokinetic (PK) and pharmacodynamics (PD) data to guide dosing. This study assessed the PK of CMS and colistin and its impact on clinical cure (CC) and acute kidney injury (AKI) in critica...
Uloženo v:
| Vydáno v: | Open Forum Infect Dis |
|---|---|
| Hlavní autoři: | , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Oxford University Press
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6253820/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofy210.1235 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|